Literature DB >> 16043164

Contemporaneous carrier-state of two or three "proatherosclerotic" variants of APOE, ICAM1, PPARA and PAI-1 genes differentiate CAD patients from healthy individuals.

Iwona Zak1, Anna Balcerzyk, Beata Sarecka, Paweł Niemiec, Zbigniew Ciemniewski, Stanisław Dylag.   

Abstract

BACKGROUND: Atherosclerosis is the most important cause of coronary artery disease (CAD). Genetic predisposition to CAD is related to polymorphisms of genes encoding products functionally involved in pathogenesis of atherosclerosis. Polymorphisms of genes participating in monocyte adhesion and diapedesis, lipid metabolism and fibrinolysis regulation may be partially responsible for this process. The aim of our study was to assess the polymorphic variants frequencies of ICAM1, APOE, PPARA and PAI-1 genes in CAD patients and healthy blood donors and to find specific arrangement of polymorphic variants which would differentiate both groups.
METHODS: We studied 146 CAD patients and 121 healthy blood donors. Polymorphisms in analyzed genes were examined using PCR-RFLP analysis.
RESULTS: We found significantly higher frequency of 5G allele of PAI-1 gene in patients than in control subjects (p = 0.038, OR = 1.44). We observed also a considerably higher frequency of contemporaneous carriers of two or three "proatherosclerotic" variants: 1) PPARA and PAI-1, 2) APOE and ICAM1 and 3) PPARA, ICAM1 and PAI-1 in CAD group comparing to control subjects. The number of "proatherosclerotic" variants carriers differentiate studied groups also independently of specific genotype arrangement.
CONCLUSION: In conclusion, contemporaneous carrier-state of two or three polymorphic variants within analyzed genes is associated with CAD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16043164     DOI: 10.1016/j.cccn.2005.06.011

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  14 in total

1.  Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with coronary artery disease risk: a meta-analysis.

Authors:  Huifeng Zhang; Pingshuan Dong; Xuming Yang; Zhenghao Liu
Journal:  Int J Clin Exp Med       Date:  2014-10-15

Review 2.  Plasminogen Activator Inhibitor-1 Polymorphisms and Risk of Coronary Artery Disease: Evidence From Meta-Analysis and Trial Sequential Analysis.

Authors:  Samira Tabaei; Melodi Omraninava; Sahar Mehranfar; Morteza Motallebnezhad; Seyedeh Samaneh Tabaee
Journal:  Biochem Genet       Date:  2022-01-18       Impact factor: 2.220

3.  Interaction between PPARA genotype and beta-blocker treatment influences clinical outcomes following acute coronary syndromes.

Authors:  Sharon Cresci; Philip G Jones; Carmen C Sucharov; Sharon Marsh; David E Lanfear; Adam Garsa; Michael Courtois; Carla J Weinheimer; Jun Wu; Michael A Province; Daniel P Kelly; Howard L McLeod; John A Spertus
Journal:  Pharmacogenomics       Date:  2008-10       Impact factor: 2.533

4.  Interactions between rs5498 polymorphism in the ICAM1 gene and traditional risk factors influence susceptibility to coronary artery disease.

Authors:  Beata Sarecka-Hujar; Iwona Zak; Jolanta Krauze
Journal:  Clin Exp Med       Date:  2008-12-02       Impact factor: 3.984

5.  The M235T polymorphism of the AGT gene modifies the risk of coronary artery disease associated with the presence of hypercholesterolemia.

Authors:  Pawel Niemiec; Iwona Zak; Krystian Wita
Journal:  Eur J Epidemiol       Date:  2008       Impact factor: 8.082

6.  Peroxisome proliferator-activated receptor [alpha] genetic variation interacts with n-6 and long-chain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study.

Authors:  Kelly A Volcik; Jennifer A Nettleton; Christie M Ballantyne; Eric Boerwinkle
Journal:  Am J Clin Nutr       Date:  2008-06       Impact factor: 7.045

7.  Synergistic effect between apolipoprotein E and apolipoprotein A1 gene polymorphisms in the risk for coronary artery disease.

Authors:  Taranjit Singh Rai; Madhu Khullar; B S Sehrawat; Monica Ahuja; Praveen Kumar Sharma; Rajesh Vijayvergiya; Anil Grover
Journal:  Mol Cell Biochem       Date:  2008-04-09       Impact factor: 3.396

8.  Synergistic effects between 561A > C and 98G > T polymorphisms of E-selectin gene and hypercholesterolemia in determining the susceptibility to coronary artery disease.

Authors:  Iwona Zak; Beata Sarecka; Jolanta Krauze
Journal:  Heart Vessels       Date:  2008-07-23       Impact factor: 2.037

9.  Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease.

Authors:  Raoudha Bahri; Esther Esteban; Pedro Moral; Mohsen Hassine; Khaldoun Ben Hamda; Hassen Chaabani
Journal:  Lipids Health Dis       Date:  2008-11-17       Impact factor: 3.876

10.  PPAR α and PPAR γ polymorphisms as risk factors for dyslipidemia in a Chinese Han population.

Authors:  Shu-Jun Gu; Zhi-Rong Guo; Zheng-Yuan Zhou; Xiao-Shu Hu; Ming Wu
Journal:  Lipids Health Dis       Date:  2014-01-26       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.